Additionally, the cGAS-STING pathway had been reported to be a promising therapeutic target in autoinflammatory, autoimmune, and degenerative diseases [49], indicating that inhibition of cGAS-STING might also be applicated in attenuating IR-induced lung injury. This evidence concerns the gene STING1 and neurodegenerative disease.